These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30691691)

  • 21. O-Acetylation is essential for functional antibody generation against Staphylococcus aureus capsular polysaccharide.
    Scully IL; Pavliak V; Timofeyeva Y; Liu Y; Singer C; Anderson AS
    Hum Vaccin Immunother; 2018 Jan; 14(1):81-84. PubMed ID: 29182428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase IIa study of the immunogenicity and safety of the novel Staphylococcus aureus vaccine V710 in adults with end-stage renal disease receiving hemodialysis.
    Moustafa M; Aronoff GR; Chandran C; Hartzel JS; Smugar SS; Galphin CM; Mailloux LU; Brown E; Dinubile MJ; Kartsonis NA; Guris D
    Clin Vaccine Immunol; 2012 Sep; 19(9):1509-16. PubMed ID: 22837094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential economic value of a Staphylococcus aureus vaccine for neonates.
    Lee BY; Ufberg PJ; Bailey RR; Wiringa AE; Smith KJ; Nowalk AJ; Higgins C; Wateska AR; Muder RR
    Vaccine; 2010 Jun; 28(29):4653-60. PubMed ID: 20472028
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Clegg J; Soldaini E; McLoughlin RM; Rittenhouse S; Bagnoli F; Phogat S
    Front Immunol; 2021; 12():705360. PubMed ID: 34305945
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of Staphylococcus aureus infections: advances in vaccine development.
    Shinefield HR; Black S
    Expert Rev Vaccines; 2005 Oct; 4(5):669-76. PubMed ID: 16221068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staphylococcal vaccine development: review of past failures and plea for a future evaluation of vaccine efficacy not only on staphylococcal infections but also on mucosal carriage.
    Botelho-Nevers E; Verhoeven P; Paul S; Grattard F; Pozzetto B; Berthelot P; Lucht F
    Expert Rev Vaccines; 2013 Nov; 12(11):1249-59. PubMed ID: 24111513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Master mechanisms of Staphylococcus aureus: consider its excellent protective mechanisms hindering vaccine development!
    Zhang X; Marichannegowda MH; Rakesh KP; Qin HL
    Microbiol Res; 2018; 212-213():59-66. PubMed ID: 29853168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A model-based analysis: what potential could there be for a S. aureus vaccine in a hospital setting on top of other preventative measures?
    Hogea C; Van Effelterre T; Cassidy A
    BMC Infect Dis; 2014 May; 14():291. PubMed ID: 24884845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and evaluation of vaccine against Staphylococcus aureus recovered from naturally occurring mastitis in she-camels.
    Aqib AI; Anjum AA; Ijaz M; Hussain R; Ahmed R; Farooqi SH; Aslam HB; Hussain K; Mehmood K; Zhang H
    Microb Pathog; 2018 Apr; 117():341-347. PubMed ID: 29510207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of a Staphylococcus aureus-cholera toxin A
    Misra N; Wines TF; Knopp CL; Hermann R; Bond L; Mitchell B; McGuire MA; Tinker JK
    Vaccine; 2018 Jun; 36(24):3513-3521. PubMed ID: 29739718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis.
    Bloom BS; Fendrick AM; Chernew ME; Patel P
    Am J Kidney Dis; 1996 May; 27(5):687-94. PubMed ID: 8629629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A vaccine to prevent infections with Staphylococcus aureus.
    Thiemermann C
    Med Sci Monit; 2002 Sep; 8(9):LE35-6. PubMed ID: 12365409
    [No Abstract]   [Full Text] [Related]  

  • 33. A D-Alanine auxotrophic live vaccine is effective against lethal infection caused by Staphylococcus aureus.
    Moscoso M; García P; Cabral MP; Rumbo C; Bou G
    Virulence; 2018 Jan; 9(1):604-620. PubMed ID: 29297750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccine review: "Staphyloccocus aureus vaccines: problems and prospects".
    Jansen KU; Girgenti DQ; Scully IL; Anderson AS
    Vaccine; 2013 Jun; 31(25):2723-30. PubMed ID: 23624095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Staphylococcus aureus Clumping Factor A Remains a Viable Vaccine Target for Prevention of S. aureus Infection.
    Anderson AS; Scully IL; Buurman ET; Eiden J; Jansen KU
    mBio; 2016 Mar; 7(2):e00225. PubMed ID: 26956591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Staphylococcus aureus: Current State of Prevalence, Impact, and Vaccine Development.
    Brett M; Bradfute SB
    Curr Pharm Des; 2015; 21(16):2131-5. PubMed ID: 25760341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global antibody response to Staphylococcus aureus live-cell vaccination.
    Selle M; Hertlein T; Oesterreich B; Klemm T; Kloppot P; Müller E; Ehricht R; Stentzel S; Bröker BM; Engelmann S; Ohlsen K
    Sci Rep; 2016 Apr; 6():24754. PubMed ID: 27103319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Status of vaccine research and development of vaccines for Staphylococcus aureus.
    Giersing BK; Dastgheyb SS; Modjarrad K; Moorthy V
    Vaccine; 2016 Jun; 34(26):2962-2966. PubMed ID: 27105559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
    Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
    mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Staphylococcus aureus Cell Wall-Anchored Protein Clumping Factor A Is an Important T Cell Antigen.
    Lacey KA; Leech JM; Lalor SJ; McCormack N; Geoghegan JA; McLoughlin RM
    Infect Immun; 2017 Dec; 85(12):. PubMed ID: 28947645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.